This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Coil Embolization of Coronary Artery Fistulas

This study has been completed.
Information provided by:
HOSPITEN Identifier:
First received: September 12, 2005
Last updated: October 16, 2008
Last verified: August 2005
Background and Purpose: Congenital coronary artery fistula (CAF) is an uncommon anomaly. In some patients they can became symptomatic, associated with significant morbidity and mortality. We report our experience in percutaneous treatment of CAF.

Condition Intervention Phase
C14 C14907933 C14907933125 G09330582163324 C14280647250 Device: Coil Phase 4

Study Type: Observational
Official Title: Coil Embolization of Coronary Artery Fistulas: A Single Centre Experience

Resource links provided by NLM:

Further study details as provided by HOSPITEN:

Study Start Date: January 2004
Estimated Study Completion Date: August 2005
Detailed Description:

Congenital coronary artery fistula (CAF) can be defined as a direct communication of a coronary artery with a cardiac chamber, great vessel, or other vascular structure, bypassing the myocardial capillary bed.

CAF is an uncommon anomaly, occurring as an incidental finding in 0.1% to 0.2% of coronary angiograms. They are not gender specific. Many patients have symptoms like congestive heart failure, infective endocarditis, myocardial ischemia, or rupture of an aneurismal fistula. Surgical closure of coronary artery fistula was initially reported in 1983 with low rates of morbidity and mortality.

Percutaneous treatment appeared as an alternative to surgery. Transcatheter closure of CAF was first utilized in 1983. Along this years, with experience and improvements in catheterization equipment and occlusion devices, CAF occlusion have been successfully performed using microcoils.

We report our experience in using microcoils to percutaneous treatment of coronary fistulas.


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Coronary artery fistulas
  • Clinical diagnosis of angina, myocardial infarction, left ventricular insufficiency, ventricular enlargement

Exclusion Criteria:

  • Age <18 or > 85 years
  • Cardiogenic shock _ severe ventricular enlargement
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00198016

Santa Cruz, Tenerife, Spain, 38001
Sponsors and Collaborators
Study Director: Zuheir Kabbani, Cardiology HOSPITEN
  More Information Identifier: NCT00198016     History of Changes
Other Study ID Numbers: HOSPITEN
Study First Received: September 12, 2005
Last Updated: October 16, 2008

Keywords provided by HOSPITEN:
coronary fistulas.
coils embolization.

Additional relevant MeSH terms:
Pathological Conditions, Anatomical processed this record on August 17, 2017